We’ve all experienced that moment of frustration when the GPS glitches and you miss an exit on the highway. The team at Tern ...

At SXSW, Tern AI demonstrated exclusively for TechCrunch that its low-cost alternative to GPS could “derive a position from ...

Tern announced on Friday that it has raised £0.22m through a placing of 19,230,769 new shares at 1.15p each, representing a 9.8% discount to the closing price on 20 February.

The greatest stories aren't just found in books! At JLF2025, iStartRajasthan brought 11 groundbreaking startups to one of India's biggest cultural stages.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

View of the world's rare Chinese Crested Tern in Rizhao City, East China's Shandong Province The Best Movies of All Time Blue Ghost becomes second private spacecraft to land on the moon Vietnamese ...

A February 2025 report by Palisades research shows that AI reasoning models lack a moral compass. They will cheat to achieve their goals. So-called Large Language Models (LLMs) will misrepresent ...

Google’s efforts to serve up AI-generated answers in search results hasn’t exactly gone according to plan. When AI Overviews rolled out last summer, the feature surprised users by crafting ...

Terns Pharmaceuticals focuses on developing weight loss and oncology medicines. Its two leading candidates, TERN-601 and TERN-501 -- both in the anti-obesity field -- are close to entering phase 2 ...

Open source software has a number of benefits over commercial products, not least the fact that it can be downloaded for free. This means anyone can analyse the code and, assuming they have the ...

Also: The billion-dollar AI company no one is talking about - and why you should care I've been exploring the latest trends that are transforming how businesses grow and succeed. If you're ...

Analysts remain bullish on Viking, but another weight loss company boasts even more significant upside potential, judging by Wall Street's predictions: Terns Pharmaceuticals (NASDAQ: TERN).